Jentsch D, Schulz V, Wendt H
Arzneimittelforschung. 1976;26(5):914-9.
Sixteen volunteers were given cyproterone acetate-2'-14C (6-chloro-17-hydroxy-1alpha,2alpha-methylene-pregna-4,6-diene-3,20-dione acetate; Androcur¿) in single doses of between 2 and 12 mg i.m. and p.o. in 19 investigations. The plasma radioactivity was then determined at suitable intervals. Urine and faeces were collected quantitatively for 12 days. After oral administration the highest concentrations in plasma were found 1--4 h after administration. The mean amounts were 2--3% of the administered dose in the plasma volume. Plasma concentrations of more than half the highest values were measured for a period of 2--8 h. Cyproterone acetate was eliminated from the body with a half-life of about 1 1/2 days for men and about 2 days for women. After oral administration in single doses of 2--12 mg the compound was almost completely absorbed.
19项研究中,16名志愿者接受了醋酸环丙孕酮-2'-14C(6-氯-17-羟基-1α,2α-亚甲基-孕甾-4,6-二烯-3,20-二酮醋酸酯;安雄),肌肉注射和口服的单剂量为2至12毫克。然后在适当的间隔时间测定血浆放射性。定量收集尿液和粪便12天。口服给药后,给药后1至4小时血浆中浓度最高。平均量为给药剂量在血浆体积中的2%至3%。血浆浓度超过最高值一半以上的时间为2至8小时。醋酸环丙孕酮从体内消除的半衰期,男性约为1.5天,女性约为2天。单剂量口服2至12毫克后,该化合物几乎完全被吸收。